Skandinaviska Enskilda Banken (SEB)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,300	Closed	-$127K	–	1089
2021 Q3	$127K	Buy	+6,300	New	+$127K	﹤0.01%	951
2020 Q3	–	Sell	-28,000	Closed	-$711K	–	1140
2020 Q2	$711K	Buy	+28,000	New	+$711K	0.01%	770